Capital Flow Monitor · Sponsors · CIK 1885962
Nanochon, Inc.
1317 SHEPHERD ST NW, WASHINGTON, DC, 20011 · 7039946099
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$4.2M
Sold
$3.6M
% sold
84.8%
Investors
39
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-05 | D ·current | 506(b) | $4.2M | $3.6M | 84.8% | 39 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Benjamin Holmes — Executive Officer / Director, Washington, DC
- Robert Creeden — Director, Washington, DC
- Sean Churchill — Director, Washington, DC
- Nick Pachuda — Director, Washington, DC
-
Kurt Jacobus — Director, Washington, DC
3 other raises
- Huxley Medical, Inc. $11.0M of $11.7M · 94.2%
- EarliTec Diagnostics, Inc. $3.5M of $7.0M · 50.0%
- RESTOR3D, Inc. $84.8M of $94.8M · 89.5%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.